Sign in

CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811489190
Phone
858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Chief Operating Officer sold 21,828 shares at $8.71 ($190,050)
  7. 4 Open-market sale Chief Business Officer sold 166,380 shares at an average $8.87 ($1,476,147)
  8. 4 Gift Director gave 350,000 shares (gift)
  9. 4 Planned sale PRESIDENT AND CEO sold 50,000 shares at $14.49 ($724,345)
  10. 4 Planned sale Chief Financial Officer sold 12,500 shares at $15.00 ($187,500)
  11. 4 Planned sale CHIEF MEDICAL OFFICER sold 50,000 shares at an average $14.08 ($703,755)
  12. 4 Planned sale Chief Commercial Officer sold 15,000 shares at $16.99 ($254,861)
  13. 4 Open-market sale 10% owner sold 740,149 shares at $18.46 ($13,663,151)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 14 · 270 filings